Get the Stockscreener App
1.10
3.51%
-0.04
After Hours:
1.10
Enlivex Therapeutics Ltd stock is traded at $1.10, with a volume of 265.24K.
It is down -3.51% in the last 24 hours and up +15.46% over the past month.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
See More
Previous Close:
$1.14
Open:
$1.15
24h Volume:
265.24K
Relative Volume:
0.07
Market Cap:
$261.12M
Revenue:
-
Net Income/Loss:
$-14.33M
P/E Ratio:
-1.6667
EPS:
-0.66
Net Cash Flow:
$-13.21M
1W Performance:
-5.17%
1M Performance:
+15.46%
6M Performance:
-29.94%
1Y Performance:
+4.76%
1-Day Range:
$1.10
$1.155
1-Week Range:
$1.10
$1.2001
52-Week Range:
$0.66
$2.10
Enlivex Therapeutics Ltd Stock (ENLV) Company Profile
Name
Enlivex Therapeutics Ltd
Sector
Industry
Phone
-
Address
-
Compare ENLV vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENLV
Enlivex Therapeutics Ltd
|
1.10 | 270.61M | 0 | -14.33M | -13.21M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Enlivex Therapeutics Ltd Stock (ENLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-02-21 | Reiterated | H.C. Wainwright | Buy |
Enlivex Therapeutics Ltd Stock (ENLV) Latest News
Enlivex Therapeutics Ltd. (NASDAQ:ENLV) Short Interest Update - MarketBeat
Enlivex Therapeutics announces new listing of RAIN token on Kraken - Yahoo Finance
Enlivex Completes $212 Million Private Placement, Expands Digital Asset Strategy - MSN
Enlivex Therapeutics (ENLV) Expands RAIN Token Accessibility wit - GuruFocus
Enlivex’s RAIN Treasury Token Debuts on Kraken to Boost Liquidity - TipRanks
Enlivex Treasury Portfolio Update: New Listing of the RAIN Token on Kraken, the Second-Largest U.S. Cryptocurrency Exchange - marketscreener.com
RAIN token jumps to Kraken, second-largest US crypto exchange - Stock Titan
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Asheville Citizen Times
Enlivex Shareholders Approve Amended Articles of Association at February 3 Meeting - The Globe and Mail
Enlivex Completes Private Placement to Fund Digital Asset Strategy - MSN
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Visalia Times-Delta
Short Interest in Enlivex Therapeutics Ltd. (NASDAQ:ENLV) Drops By 66.6% - MarketBeat
Enlivex Therapeutics (ENLV) Expands Reach with RAIN Token Listin - GuruFocus
Enlivex Lists RAIN Treasury Token on WhiteBIT to Boost Liquidity - TipRanks
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on WhiteBIT, a Leading Cryptocurrency Exchange - The Manila Times
Token powering real-world events markets lands on Europe’s top crypto exchange - Stock Titan
Analyst Upgrade: Is ProShares Trust ProShares Short Russell2000 forming bullish engulfing patternsWeekly Investment Recap & Community Driven Trade Alerts - baoquankhu1.vn
Can Enlivex Therapeutics Ltd sustain earnings growthMarket Movers & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Enlivex Therapeutics to delist from Tel Aviv Stock Exchange in April By Investing.com - Investing.com India
Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq - MEXC
Enlivex Shares to Trade Exclusively on NASDAQ - Baystreet.ca
Enlivex Therapeutics to delist from Tel Aviv Stock Exchange in April - Investing.com Australia
Enlivex to Delist from Tel Aviv and Shift Trading Exclusively to Nasdaq - TipRanks
Biotech Enlivex shifts share trading to Nasdaq, leaves Tel Aviv in April - Stock Titan
Published on: 2026-01-22 15:37:58 - baoquankhu1.vn
Market Moves: What are Nukkleus Incs technical support levelsTrade Ideas & Short-Term High Return Strategies - baoquankhu1.vn
Guidance Update: Is Enlivex Therapeutics Ltd vulnerable to short sellers2025 Sector Review & Reliable Breakout Forecasts - baoquankhu1.vn
Risk Analysis: Can Enlivex Therapeutics Ltd reach all time highs this year2025 Trading Volume Trends & Weekly Stock Performance Updates - baoquankhu1.vn
Can Enlivex Therapeutics Ltd reach all time highs this yearQuarterly Risk Review & Verified Momentum Stock Alerts - baoquankhu1.vn
Enlivex Therapeutics (NASDAQ:ENLV) Upgraded to Hold at Wall Street Zen - MarketBeat
Aug Spikes: Can Enlivex Therapeutics Ltd reach all time highs this yearAnalyst Upgrade & Safe Entry Trade Reports - baoquankhu1.vn
Breakouts Watch: Can Enlivex Therapeutics Ltd grow without external fundingJuly 2025 Opening Moves & Fast Gain Swing Alerts - baoquankhu1.vn
New Highs: Will Enlivex Therapeutics Ltd outperform its industry peers2025 Macro Impact & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Enlivex bets big on RAIN, crypto prediction markets - MEXC
Enlivex bets big on crypto prediction markets while advancing osteoarthritis therapy - Bitget
Analyst Sees Massive Upside For Penny Stock Enlivex After RAIN Token Gains Momentum - Benzinga
Enlivex Therapeutics (ENLV) Price Target Increased by 85.71% to 13.26 - Nasdaq
What is HC Wainwright's Estimate for ENLV FY2025 Earnings? - MarketBeat
Aug EndMonth: Is now the right time to enter Enlivex Therapeutics LtdMarket Volume Report & Technical Pattern Recognition Alerts - baoquankhu1.vn
Chart Watch: Is Enlivex Therapeutics Ltd stock affected by interest rate hikesStock Surge & AI Enhanced Execution Alerts - Bộ Nội Vụ
Enlivex Therapeutics Ltd. (ENLV) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Enlivex Therapeutics stock price target raised to $13 by H.C. Wainwright - Investing.com South Africa
ENLV: Analyst Raises Price Target Significantly | ENLV Stock New - GuruFocus
Enlivex Therapeutics Ltd Stock (ENLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):